Program
Monday, April 16 2018
09:00-9:30
Arrival of Early Carrier Investigators (ECIs)
Registration of ECIs
Poster hanging
9:30-13:00
Group of participants: ECIs
- Welcome by Prof. Helen Papadaki (Meeting host), practical Information and overview of the meeting.
- Speed dating round of ECIs: Who are they? What is the focus of their work? Which MDSC type are they working with? In which disease type? Which methods are used in their lab? Which methods are they interested in learning/establishing?
- Campus tour - Location: Medical School of the University of Crete
13:00-14:00 - Lunch (Location: Hotel Astoria)
Parallel sessions:
14:00-16:00 - ECI Workshop Part I
Group of participants: ECIs, non-MC WG facilitators, non-MC members of the COST Action
- Key note lecture: MDSCs reserves and function in normal states and human diseases.
Speaker: Viktor Umansky
- Separate pre-defined groups of ECIs will try to solve preselected questions/queries on MDSCs under the supervision of facilitators/tutors (WG members). Findings and proposals will be presented and discussed with the WG members in 17-4-2018.
Chairs: Panos Verginis, Nicole Bizymi.
- Question/Query: Early stage MDSCs: Are these cells a third MDSC-subset?
Start by giving the recent recommendations on the nomenclature and identification of M-MDSCs and PMN-MDSCs. Then, try to answer the question based on evidence from the literature. Suggest experimental ways to prove your answer.
Facilitator/Tutor: AncaDorhoi
- Question/Query: Epigenetic studies for MDSCs.
Discuss their usage. Provide literature.
Facilitator/Tutor: Panos Verginis
3. Question/Query: MDSCs as biomarkers: Is it possible in the clinical setting?
Discuss their usage. Where is the field now? What is feasible to investigate? Suggest experimental ways to investigate them as biomarkers (molecular signatures, functional assays).
Facilitator/Tutor: EstelaPaz-Artal
- Question/Query: Animal models for MDSCs: Pros and Cons
Give the main animal models. Explain the pros and cons. How to translate the results into the human setting. Give your own experience based on your research and how you deal with it.
Facilitator/Tutor: GennadiyZelinskyy
5. Question/Query: Can MDSCs work as therapeutic targets? Identify 5 (at least) agents (new or old) that are known to affect their number or function.
Provide papers supporting your answer. Explain the pathways affected by the evidence and how this can facilitate the therapeutic strategy. Focus on older agents now found to affect also MDSCs.
Facilitator/Tutor: Katarzyna Barczyk-Kahlert
14:00-16:00 - COST Management Committee Meeting
Group of participants: MC members of the COST Action
- Welcome to participants
- Verification of the presence of two-thirds of the Participating COST Countries or, if applicable, a quorum
- Adoption of agenda
- Approval of minutes and matters arising of last meeting
- Update from the Action Chair
(α) Status of Action: start and end dates of Action, participating COST countries, participating NNC/IPC institutions and Specific Organisations.
(b) Short Term Scientific Missions (STSM): review of completed reports and new applications.
- Update from the Grant Holder: Action budget status
- Update from the COST Association, if a representative is present
- Monitoring of the Action
- Implementation of COST policies on:
- Promotion of gender balance and Early Career Investigators (ECI)
- Inclusiveness and Excellence (see below list of Inclusiveness Target Countries)
- Follow-up of MoU objectives: progress report of working groups
- Scientific planning
- Scientific strategy (MoU objectives, GP Goals, WG tasks and deliverables)
- Action Budget Planning
- Long-term planning (including anticipated locations and dates of future activities)
- Dissemination planning (Publications and outreach activities)
- Requests to join the Action from:
- COST countries
- Institutions in Near Neighbouring Countries, International Partner Countries, and/or Specific
- Organisations: EU agencies, European RTD Organisation, International Organisations
- AOB
- Location and date of next meeting
- Summary of MC decisions
- Closing
16:00-16:30 - Coffee Break
16:30-17:30 - Joint Session
Group of participants: All members of COST Action, ECIs
- Welcome to all participants by Sven Brandau. Information about the Meeting.
- Mye-EUNITER related issues.
- Opening Lecture: Chandax - Candia - Heraklion. A short trip in time.
Liana Starida, Archeologist.
18:00-20:00 - Heraklion: Historic Downtown – Guided Walking Tour
Group of participants: all members of COST Action, ECIs.
20:30 - Dinner